Global Transdermal Drug Patches Market Report 2021: New Patch Designs will Keep Expanding Through 2028
Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Transdermal Drug Patches to 2028" report has been added to ResearchAndMarkets.com's offering.
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver.
Advances in synthetic materials and patch design have led to patches that are more aesthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package.
Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings.
Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2028.
What You Will Learn
Analyzes and evaluates current transdermal drug patch markets and products and assesses the market potential for existing and probable future products
Analyzes patch designs, technologies and patch development issues
Profiles patch manufacturers and third-party transdermal supply chain companies
Provides detailed assessments of more than forty patch products in more than a dozen product categories
Provides market data and forecasts to 2028
Profiles transdermal drug patch product providers, their product development activity, and strategies
Evaluates the impact of economic, technology, and regulatory factors
Key Topics Covered:
Executive Summary
The Market Opportunity
Transdermal Drug Delivery Dynamics
Demand Drivers
Competitive Landscape
Factors Limiting Growth
Pharmacokinetics & Dosage Forms
Patch Manufacturing Dynamics
Patch Manufacturing Company Profiles
Product Analysis -
FDA-Approved Drugs Delivered via Transdermal Patches
Alkaloids
Androgens
Antidepressants
Antiemetics
Antispasmodics
CNS Stimulants
Cholinesterase Inhibitors
Dopamine Agonists
Hormone Replacement
Hypotensive Agents
Local Anesthetics
NSAIDs
Opioid Analgesics
Progestrins
Trinitrates
Development-stage Drug Patches
Market Analysis - Transdermal Drug Patch Therapeutics
ADHD
Addiction
Contraception
Cardiovascular/Angina
Depression
Hormone Replacement Therapy
Hypertension
Motion Sickness
Neurology
Osteoporosis
Pain Management
Market Factors
Regulatory Issues
IP and Expiring Patents
Rx-to-OTC Switching
Patient Compliance and Ease of Use
Healthcare Economics
Company Profiles
3M
Altaris
Kindeva
Acino
Actavis
Alpharma
Pfizer
Aveva Drug Delivery Systems
Corium
Grunenthal
Hisamitsu
J&J
Janssen
Lohmann Therapie Systems
Mylan
Novartis
Noven
Kyowa Kirin
Mundipharma
Shire
Teikoku Seiyaku
Schwarz
Merck
Agile Therapeutics
Purdue
Scilex Pharmaceuticals
Bayer Healthcare
Boehringer Ingelheim
Galen SpecialtyPFizer
IBSA
Averitas Pharma
Sancuso
For more information about this report visit https://www.researchandmarkets.com/r/sxaqu4
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900